Verrica Pharmaceuticals (VRCA) Enterprise Value (2018 - 2026)
Verrica Pharmaceuticals' Enterprise Value was $93.93 million in Q2 2026, up 179.1% from $33.65 million a year earlier and up 33.7% from the prior quarter.
Verrica Pharmaceuticals (VRCA) Enterprise Value (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, Verrica Pharmaceuticals' Enterprise Value was $22.09 million through Jun 30, 2026; for FY2025, it came in at $58.37 million.
- Enterprise Value shows a five-year compound annual growth rate of -27.0% (FY2020 to FY2025).
- In earlier years, Enterprise Value was -$10.06 million in FY2024, $240.92 million in FY2023 (+303.7%), $59.68 million in FY2022 (-74.7%) and $236.32 million in FY2021 (-16.2%).
- The Q2 2026 figure marks the highest quarterly Enterprise Value since Q2 2024.
- Compared with a year earlier, Enterprise Value was higher in two of the last six quarters, with growth averaging 72.9%.
- The best year-over-year quarter for Enterprise Value over five years was Q1 2026 (growth of 540.3%); the worst was Q2 2022 (a decline of 97.3%).
- Per Business Quant data, VRCA's Enterprise Value in the three quarters before Q2 2026 was $70.28 million (Q1 2026), $58.37 million (Q4 2025) and $19.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Verrica Pharmaceuticals | 62.02 Mn | -21.03 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 93.93 Mn |
| Mar 31, 2026 | 70.28 Mn |
| Dec 31, 2025 | 58.37 Mn |
| Sep 30, 2025 | 19.80 Mn |
| Jun 30, 2025 | 33.65 Mn |
| Mar 31, 2025 | 10.98 Mn |
| Dec 31, 2024 | -10.06 Mn |
| Sep 30, 2024 | 43.12 Mn |
| Jun 30, 2024 | 277.57 Mn |
| Mar 31, 2024 | 202.19 Mn |
| Dec 31, 2023 | 240.92 Mn |
| Sep 30, 2023 | 79.11 Mn |
| Jun 30, 2023 | 186.35 Mn |
| Mar 31, 2023 | 212.04 Mn |
| Dec 31, 2022 | 59.68 Mn |
| Sep 30, 2022 | 87.52 Mn |
| Jun 30, 2022 | 7.61 Mn |
| Mar 31, 2022 | 173.63 Mn |
| Dec 31, 2021 | 236.32 Mn |
| Sep 30, 2021 | 323.55 Mn |
Verrica Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=VRCA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "VRCA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=VRCA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();